ImmuCell Stock Forecast for 2023 - 2025 - 2030

Updated on 03/28/2024

Stock Rating
0
Price Target
$0.00
Consensus
-
Upside
167.69%
Analysts
0
Stock Rating
0
Upside
167.69%
Analysts
0
Price Target
$0.00
-

ImmuCell Fair Value Forecast for 2023 - 2025 - 2030

In the last two years, ImmuCell's Price has grown from $0.00 to $0.00 – a 100.00% increase. Next year, analysts are expecting Fair Value to reach $0.00 – an increase of 100.00%. Over the next six years, the forecast is for Fair Value to grow by 100.00%.

2025 Fair Value Forecast
$0.00
2026 Fair Value Forecast
$0.00
2027 Fair Value Forecast
$0.00
2028 Fair Value Forecast
$0.00
2029 Fair Value Forecast
$0.00
2030 Fair Value Forecast
$0.00

ImmuCell Revenue Forecast for 2023 - 2025 - 2030

In the last two years, ImmuCell's Revenue has grown from $15.34M to $18.57M – a 21.06% increase. In the next year, 0 analysts estimate that ImmuCell's Revenue will decrease by 4.35%, reaching $17.76M. According to professional forecasts, in 2030, ImmuCell's Revenue will decrease by 4.15%, reaching $17.80M.

2023 Rev Forecast
$0.02B
2024 Rev Forecast
$0.02B
2025 Rev Forecast
$0.02B
2026 Rev Forecast
$0.02B
2027 Rev Forecast
$0.02B
2028 Rev Forecast
$0.02B
2029 Rev Forecast
$0.02B
2030 Rev Forecast
$0.02B

ImmuCell Dividend per Share Forecast for 2023 - 2025 - 2030

ImmuCell Free Cash Flow Forecast for 2023 - 2025 - 2030

ImmuCell EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, ImmuCell's EBITDA has decreased by 80.41%, going from $970.00k to $190.00k. In the next year, analysts believe that EBITDA will reach $1.84M – an increase of 866.27%. For the next eight years, the forecast is for EBITDA to grow by 18687.56%.

2023 EBITDA Forecast
$0.00B
2024 EBITDA Forecast
$0.01B
2025 EBITDA Forecast
$0.04B
2026 EBITDA Forecast
$0.01B
2027 EBITDA Forecast
$0.02B
2028 EBITDA Forecast
$0.03B
2029 EBITDA Forecast
$0.08B
2030 EBITDA Forecast
$0.04B

ImmuCell EBIT Forecast for 2023 - 2025 - 2030

ImmuCell's EBIT has grown In the last two years, rising from $-1.38M to $-2.30M – a growth of 66.67%. For the following year, the 0 analysts predict that ImmuCell's EBIT will drop by 136.06%, reaching $829.30k. In 2030, the professionals' prediction is that ICCC's EBIT will decrease by 53.25%, reaching $-1.08M.

2023 EBIT Forecast
$829.30k
2024 EBIT Forecast
$-1649788.41
2025 EBIT Forecast
$-1013135.06
2026 EBIT Forecast
$-458511.16
2027 EBIT Forecast
$-969093.90
2028 EBIT Forecast
$-1392620.24
2029 EBIT Forecast
$-1568368.91
2030 EBIT Forecast
$-1075326.00

ImmuCell EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last two years, ImmuCell's EPS has grown from $-0.14 to $0.00 – a 100.00% increase. Next year, analysts are expecting EPS to reach $0.00 – an increase of 100.00%. Over the next six years, the forecast is for EPS to grow by 100.00%.

2025 EPS Forecast
$0.00
2026 EPS Forecast
$0.00
2027 EPS Forecast
$0.00
2028 EPS Forecast
$0.00
2029 EPS Forecast
$0.00
2030 EPS Forecast
$0.00